RemSleep Holdings (RMSL) Non Operating Income (2013 - 2025)
RemSleep Holdings recorded quarterly Non Operating Income of -$114258.0 in Q4 2025, down 295.67% quarter-over-quarter from -$28877.0 in Q3 2025, and up 20.41% year-over-year from -$94891.8 in Q4 2024.
RemSleep Holdings' Non Operating Income history runs 13 years deep, the most recent figure standing at -$114258.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 20.41% year-over-year to -$114258.0; the TTM figure through Dec 2025 stood at -$252528.0 (up 11.22% YoY), while the FY2025 annual figure was -$252528.0, up 11.22% from the prior year.
- Non Operating Income came in at -$114258.0 for Q4 2025 at RemSleep Holdings, down from -$28877.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $71266.0 in Q2 2024 to a low of -$2.2 million in Q2 2021.
- A 5-year average of -$221676.8 and a median of -$83794.0 in 2024 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 4043.88% in 2024 and fell as far as 9472.93% in 2024.
- RemSleep Holdings' Non Operating Income stood at -$43878.0 in 2021, then jumped by 87.11% to -$5656.0 in 2022, then soared by 115.81% to $894.0 in 2023, then tumbled by 16157.72% to -$143556.0 in 2024, then grew by 20.41% to -$114258.0 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$114258.0, -$28877.0, and -$155220.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.80 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 | -114,258.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -114,258.00 |
| Sep 30, 2025 | -28,877.00 |
| Jun 30, 2025 | -155,220.00 |
| Mar 31, 2025 | 45,827.00 |
| Dec 31, 2024 | -143,556.00 |
| Sep 30, 2024 | -83,794.00 |
| Jun 30, 2024 | 71,266.00 |
| Mar 31, 2024 | -128,365.00 |
| Sep 30, 2023 | 894.00 |
| Jun 30, 2023 | -1,807.00 |
| Mar 31, 2023 | -5,283.00 |
| Dec 31, 2022 | -5,656.00 |
| Sep 30, 2022 | -5,656.00 |
| Jun 30, 2022 | -95,649.00 |
| Mar 31, 2022 | -161,741.00 |
| Dec 31, 2021 | -43,878.00 |
| Sep 30, 2021 | -750,296.00 |
| Jun 30, 2021 | -2.23 Mn |
| Mar 31, 2021 | -377,202.00 |
| Dec 31, 2020 | -451,419.00 |
| Sep 30, 2020 | -213,367.00 |
| Jun 30, 2020 | 153,308.00 |
| Mar 31, 2020 | -194,130.00 |
| Dec 31, 2019 | -782,536.00 |
| Sep 30, 2019 | 35,292.00 |
| Jun 30, 2019 | -257,377.00 |
| Mar 31, 2019 | -541,863.00 |
| Dec 31, 2018 | 5,793.00 |
| Sep 30, 2018 | -105,980.00 |
| Jun 30, 2018 | -623.00 |
| Mar 31, 2018 | -17,511.00 |
| Dec 31, 2017 | -631.00 |
| Sep 30, 2017 | -630.00 |
| Jun 30, 2017 | -1,239.00 |
| Dec 31, 2016 | -4,958.00 |
| Sep 30, 2016 | 12.00 |
| Mar 31, 2016 | 2,389.00 |
| Dec 31, 2015 | -1,626.00 |
| Mar 31, 2015 | 1,523.00 |
| Dec 31, 2014 | 227.00 |
| Dec 31, 2013 | 141,762.00 |
| Sep 30, 2013 | -315,769.00 |
| Jun 30, 2013 | -1.11 Mn |